2004

233. Bailey JP, Nieport KM, Herbst MP, Srivastava S, Serra R (PP) , Horseman ND : Prolactin and transforming growth factor-beta signaling exert opposing effects on mammary gland morphogenesis, involution, and the Akt-forkhead pathway. Mol Endocrinol 18:1171-1184, 2004.

234. Beenken SW (CA, P1) , Bland KI (CA) : Breast cancer genetics. In: Ellis CN (ed), Inherited Cancer. Springer-Verlag , New York , NY, pp. 91-133, 2004.

235. Bonner JA, Buchsbaum DJ (P5) , Rogers BE, Grizzle WE (CC) , Trummell HQ, Curiel DT (P4) , Fiveash JB, Ove R, Raisch KP: Adenoviral vector-mediated augmentation of epidermal growth factor receptor (EGFr) enhances the radiosensitization properties of anti-EGFr treatment in prostate cancer cells. Int J Radiat Oncol Biol Phys 58:950-958, 2004.

236. Bonner JA, Buchsbaum DJ (P5) , Russo SM, Fiveash JB, Trummell HQ, Curiel DT (P4) , Raisch KP: Anti-EGFR mediated radiosensitization as a result of augmented EGFR expression. Int J Radiat Oncol Biol Phys 59 (Suppl):2-10, 2004.

237. Casillas MA, Lopatina N, Andrews LG, Tollefsbol TO (PP) : Transcriptional control of the DNA methyltransferases is altered in aging and neoplastically-transformed human fibroblasts. Mol Cell Biochem 252:33-43, 2003.

238. Chhieng DC (CC) , Frost AR (CC, P2, P3) , Niwas S, Weiss HL, Grizzle WE (CC) , Beenken SW (CA, P1) : Intratumor heterogeneity of biomarker expression in breast carcinomas. Biotech Histochem 79:25-36, 2004.

239. Cope MB, Steele VE, Lubet RA, Eto I, Juliana MM, Hill DL (P1) , Grubbs CJ (P1) : Efficacy of 9-cis-retinoic acid and N-(4-hydroxyphenyl)retinamide alone and in combination in mammary cancer prevention. Oncol Rep 11:465-469, 2004.

240. Du F, Chu WJ, Yang B, den Hollander JA, Ng TC (PP) : In vivo GABA detection with improved selectivity and sensitivity by localized double quantum filter technique at 4.1T. J Magn Reson Imaging 22:103-108, 2004.

241. Esserman L, Bland KI (CA) : Introduction: A surgical strategy for optimizing breast cancer therapy. Ann Surg Oncol 11:1S-2S, 2004.

242. Fabian CJ, Kimler BF (PP) , Anderson J, Tawfik OW, Mayo MS, Burak WE Jr, O'Shaughnessy JA, Albain KS, Hyams DM, Budd GT, Ganz PA, Sauter ER, Beenken SW (CA, P1) , Grizzle WE (CC) , Fruehauf JP, Arneson DW, Bacus JW, Lagios MD, Johnson KA, Browne D: Breast cancer chemoprevention phase I evaluation of biomarker modulation arzoxifene, a third generation selective estrogen receptor modulator. Clin Cancer Res 10:5403-5417, 2004.

243. Forero A (P5, CD) , Weiden PL , Vose JM, Knox SJ, LoBuglio AF (P2) , Hankins J, Goris ML, Picozzi VJ, Axworthy DB, Breitz HB, Sims RB, Ghalie RG, Shen S, Meredith RF (P6) : Phase I trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma. Blood 104:227-236, 2004, plus Journal cover.

244. Glasgow JN, Kremer EJ, Hemminki A (CD) , Siegal GP (CB) , Douglas JT, Curiel DT (P4) : An adenovirus vector with a chimeric fiber derived from canine adenovirus type 2 displays novel tropism. Virology 324:103-116, 2004.

245. Grizzle WE (CC) , Meleth S, Petricoin EF, Liotta LA: Clarification in the point/counterpoint discussion related to surface-enhanced laser desorption/ionization time-of-flight mass spectrometric identification of patients with adenocarcinomas of the prostate. Clin Chem 50:1475-1477, 2004.

246. Harms JF, Welch DR (P2) , Samant RS (PP) , Shevede-Samant LR (PP) , Miele ME, Babu GR, Goldberg SF, Gilman VR, Sosnowski DM, Campo DA, et al.: A small molecule antagonist of the alpha-v-beta-3 integrin suppresses MDA-435 skeletal metastasis. Clin Exp Metastasis 21:119-128, 2004.

247. Jaeger EB, Chekmareva MA, Tennant TR, Luu HH, Hickson JA, Chen SL, Samant RS (PP) , Sokoloff MH, Rinker-Schaeffer CW: Inhibition of prostate cancer metastatic colonization by approximately 4.2 Mb of human chromosome 12. Int J Cancer 108:15-22, 2004.

248. Kanerva A, Bauerschmitz GJ, Yamamoto M (P4) , Lam JT, Alvarez RD, Siegal GP (CB) , Curiel DT (P4) , Hemminki A (CD) : A cyclooxygenase-2 promoter-based conditionally replicating adenovirus with enhanced infectivity for treatment of ovarian adenocarcinoma. Gene Ther 11:552-559, 2004.

249. Le LP, Everts M, Dmitriev IP (CD) , Davydova JG, Yamamoto M (P4) , Curiel DT (P4) : Fluorescently labeled adenovirus with pIX-EGFP for vector detection. Mol Imaging 3:105-116, 2004.

250. Li L, Hsu HC, Stockard CR, Yang P, Zhou J, Wu Q, Grizzle WE (CC) , Mountz JD: IL-12 inhibits thymic involution by enhancing IL-7 and IL-2-induced thymocyte proliferation. J Immunol 172:2909-2916, 2004.

251. Mahendra G, Kumar S, Isayeva T, Mahasreshti P, Curiel DT (P4) , Stockardt CR, Grizzle WE (CC) , Alapati V, Singh RK, Siegal GP (CB) , Meleth S, Ponnazhagan S: Anti-angiogenic cancer gene therapy by adeno-associated virus 2-mediated stable expression of soluble FMS-like tyrosine kinase-1 receptor. Cancer Gene Therapy, 2004.

252. Mastro AM, Gay CV, Welch DR (P2) , Donahue HJ, Jewell J, Mercer R, DiGirolamo D, Chislock EM, Guttridge K: Breast cancer cells induce osteoblast apoptosis: A possible contributor to bone degradation. J Cellular Biochemistry 91:265-276, 2004.

253. Meehan WJ, Samant RS (PP) , Hopper JE, Carrozza MJ, Shevde LA, Workman JL, Eckert KA, Verderame MF, Welch DR (P2) : Breast cancer metastasis suppressor 1 (BRMS1) forms complexes with retinoblastoma-binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcription. J Biol Chem 279:1562-1569, 2004.

254. Mittal A, Pate MS, Wylie RC, Tollefsbol TO (PP) , Katiyar SK : EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis. Int J Oncol 24:703-710, 2004.

255. Muminova Z, Strong TV (PP) , Shaw DR (P5) : Characterization of human mesothelin transcripts in pancreatic and ovarian cancer. BMC Cancer 4:19, 2004.

256. Pandya A, Talley LI (PP) , Frost AR (CC, P2, P3) , Fitzgerald TJ, Trivedi V, Chakravarthy M, Chhieng CF (CC) , Grizzle WE (CC) , Krontiras H (P3, PP, CD) , Bland KI (CA) , LoBuglio AF (P2) , Ruppert SM (P3) , Ruppert J (P3) : Nuclear localization of KLF4 is associated with an aggressive phenotype in early stage breast cancer. Clinical Cancer Res 10:2709-2719, 2004.

257. Ponnazhagan S, Mahendra G, Kumar S, Shaw DR (P5) , Stockard CR, Grizzle WE (CC) , Meleth S: Adeno-associated virus 2-mediated anti-angiogenic cancer gene therapy: Long-term efficacy of a vector encoding angiostatin and endostatin over vectors encoding a single factor. Cancer Res 64:1781-1787, 2004.

258. Ponnazhagan S, Mahendra G, Lima J, Aldrich W, Jenkins C, Ren C, Kumar S, Kallman L, Strong TV (PP) , Shaw DR (P5) , Triozzi PL (P5) : Augmentation of anti-tumor activity of a recombinant adeno-associated virus carcinoembryonic antigen vaccine with plasmid adjuvants. Human Gene Ther 15:856-864, 2004.

259. Qu Z (P2) , Thottassery JV (PP) , Van Ginkel S, Manuvakhova M, Westbrook L, Roland-Lazenby C, Hays S, Kern FG (P2) : Homogeneity and long-term stability of tetracycline-regulated gene expression with low basal activity by using the rtTA2S-M2 transactivator and insulator-flanked reporter vectors. Gene 327:61-73, 2004.

260. Rodriguez-Burford C (CC) , Chhieng DC (CC) , Stockard CR, Kleinberg MJ, Barnes MN , Partridge EE, Weiss HL, Grizzle WE (CC) : p53 and erbB-2 are not associated in matched cases of primary and metastatic ovarian carcinomas. Disease Markers 19:11-17, 2004.

261. Samant RS (PP) , Meehan WJ, Hopper JE, Workman JL, Carrozza MJ, Shevede-Samant LR (PP) , Verderame MF, Eckert KE, Welch DR (P2) : Interaction of the BRMS1 metastasis suppressor with RBP1 and mSin3 histone deacetylase complex. J Biol Chem 279:1562-1569, 2004.

262. Straughn JM, Shaw DR (P5) , Guerrero A, Bhoola SM, Racelis A, Wang Z, Chiriva-Internati M, Grizzle WE (CC) , Alvarez RD, Lim SH, Strong TV (PP) : Expression of sperm protein 17 (Sp17) in ovarian cancer. International J Cancer 108:805-811, 2004.

263. Tester AM, Waltham M, Oh SJ, Bae SN, Bills MM, Walker EC, Kern FG (P2) , Stetler-Stevenson WG, Lippman ME, Thompson EW: Pro-matrix metalloproteinase-2 transfection increases orthotopic primary growth and experimental metastasis of MDA-MB-231 human breast cancer cells in nude mice. Cancer Res 64:652-658, 2004.

264. Thottassery JV (PP) , Sun Y, Westbrook L, Rentz S, Manuvakhova M, Qu Z (P2) , Samuel S, Upshaw R, Poe A, Kern FG (P2) : Prolonged ERK1/2 activation during FGF-1 or heregulin b 1 induced antiestrogen-resistant growth of breast cancer cells is resistant to MEK inhibitors. Cancer Res 64:4637-4647, 2004.

265. Welch DR (P2) : Microarrays bring new insights into understanding of breast cancer metastasis to bone. Breast Cancer Res 6:61-64, 2004.

266. Whiteside MA, Chen DT (CB, PP) , Desmond RA, Abdulkadir SA, Johanning GL: A novel time-course cDNA microarray analysis method identifies gene associated with the development of cisplatin resistance. Oncogene 23:744-752, 2004.

267. Zhu ZB, Makhija SK , Lu B, Wang M, Kaliberova L, Liu B, Rivera AA, Nettelbeck DM, Mahasreshti PJ, Leath CA , Barker S, Yamamoto M (P4) , Li F, Alvarez RD , Curiel DT (P4) : Transcriptional targeting of tumors with a novel tumor-specific surviving promoter. Cancer Gene Therapy 11:256-262, 2004.

268. Zhu ZB, Makhija SK , Lu B, Wang M, Rivera AA, Preuss M, Zhou F, Siegal GP (CB) , Alvarez RD , Curiel DT (P4) : Transport across a polarized monolayer of Caco-2 cells by transferrin receptor-mediated adenovirus transcytosis. Virology 325:116-128, 2004.

2004 In Press

269. Beenken SW (CA, P1) , Wagner FB, Bland KI (CA) : History of the therapy of breast cancer. In: Bland KI, Copeland EM III (eds), The Breast, 3rd Edition. W.B. Saunders, Philadelphia , PA , 2004, In Press.

270. Bland KI (CA) , Krontiras H (P3, PP, CD) : Wound care and complications of mastectomy. In: Bland KI (ed), Breast 3rd Ed, W.B. Saunders, 2004, In Press.

271. Bonner JA, Buchsbaum DJ (P5) , Russo SM, Fiveash JB, Curiel DT (P4) , Raisch KP: A gene therapy-based approach for increasing tumor cell expression of epidermal growth factor (EGFr). Semin Radiat Oncol, 2004, In Press.

272. Buchsbaum DJ (P5) , Khazaeli MB (P6) , LoBuglio AF (P2) , Axworthy DS, Schultz J, Chaudhuri TR, Zinn KR (CD) : Imaging and biodistribution of pretargeted CC49sFv4/SA fusion protein and radiolabeled DOTA-biotin in an intraperitoneal tumor model. Clin Cancer Res, 2004, In Press.

273. Fabian CJ, Kimler BF (PP) , Mayo SM, Grizzle WE (CC) , Masood S, Ursin G: Clinical approaches to the discovery and testing of new breast cancer prevention drugs. Cancer Chemoprevention 2: Strategies for Chemoprevention, 2004, In Press.

274. Korokhov N, Mikheeva G, Krendelshchikov A, Belousova N, Simonenko V, Krendelshchikova V, Pereboev A, Kotov A, Kotova O, Triozzi PL (P5) , Aldrich WA , Banerjee P, Curiel DT (P4) , Krasnykh VN (PP) : Targeting of adenovirus via a protein bridge approach combined with genetic modification of the viral capsid. J Virol, 2004, In Press.

275. Krontiras H (P3, PP, CD) , De Los Santos JF, Bland KI (CA) : Breast conservation therapy in invasive breast cancer. In: Bland KI (ed), Breast 3rd Edition, W.B. Saunders, 2004, In Press.

276. Lima J, Jenkins C, Hamilton N, Triozzi PL (P5) , Shaw DR (P5) , Strong TV (PP) : A DNA vaccine encoding genetic fusions of CEA and GM-CSF. J Immunother, 2004, In Press.

277. Myers RB, Manne U, Grizzle WE (CC) , Deshane J, Wright M, Curiel DT (P4) : Intracellular antibody to p185erbB-2 kills malignant prostatic cells. Tumor Targeting, 2004, In Press.

278. Serra R (PP) , Crowley M: TGF-betas in mammary gland development and breast cancer. Breast Disease, 2004, In Press.

279. Straughn JM, Shaw DR (P5) , Strong TV (PP) : Some remarks the somatic expression of Sperm Protein 17. Letter to the Editor: Response to the Letter to the Editor, Int J Cancer, 2004, In Press.

280. Timares L, Pustilnik TB, Hemminki A (CD) , Perebeov A, Krasnykh VN (PP) , Tillman B, Alvarez RD, Curiel DT (P4) : Adenovirus-modified dendritic cell-based vaccines. Mol Cancer Therapy, 2004, In Press.